Senior Product Applications Scientist, Advanced Therapies
Thermo Fisher ScientificFull Time
Senior (5 to 8 years)
Candidates must possess a Bachelor's degree (BA/BS) and ideally an advanced degree in a scientific or business field. A minimum of 8-10 years of experience in the healthcare, biotech, or pharmaceutical industry, with a preference for cell therapy experience, is required. A proven track record in account management, particularly in oncology, hematology, or cell therapy, is essential, along with a strong operational understanding of academic medical centers or transplant centers. Preferred qualifications include an MBA or related advanced degree, 5+ years of experience in hematology/oncology or bone marrow transplantation, prior experience launching or supporting cell or gene therapy products, familiarity with site operations, patient access pathways, and clinical treatment logistics, and previous experience working in cross-functional field-based teams. Willingness to travel up to 50% is also a requirement.
The Orca T Account Manager (OTAM) will act as the primary liaison between Orca Bio and Authorized Treatment Centers (ATCs), building and managing key relationships with decision-makers and stakeholders. Responsibilities include supporting clinical site readiness and execution, driving appropriate use of Orca Bio’s investigational therapies, and ensuring a smooth and effective experience for clinical sites, physicians, and other healthcare stakeholders. This involves leading site onboarding activities, serving as the on-the-ground expert for logistics and operational readiness, and overseeing product handling, including Chain of Identity (COI) and Chain of Custody (COC) compliance. The OTAM will also educate site personnel on therapies and clinical data, work closely with cross-functional teams to resolve barriers, and facilitate communication of updates. Additionally, they will analyze account performance, identify opportunities to optimize site engagement and therapy utilization, gather and share market insights, and represent Orca Bio at key conferences.
Develops and commercializes cell therapies
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.